Discontinued — last reported Q4 '25
EPS (Diluted)
Earnings Per ShareEli Lilly EPS (Diluted) increased by 19.0% to $7.39 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 51.4%, from $4.88 to $7.39. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 39.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A narrowing gap between basic and diluted EPS suggests less potential for future shareholder dilution.
Detailed definition
A performance metric that calculates earnings per share by assuming all convertible securities, such as stock options an...
Peer comparison
In the technology sector, where stock-based compensation is prevalent, this is often considered the more accurate reflection of shareholder value than basic EPS.
is_eps_dilutedHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.53 | $1.22 | $1.88 | $2.10 | $1.05 | $1.61 | $2.14 | $1.49 | $1.95 | -$0.06 | $2.42 | $2.48 | $3.28 | $1.07 | $4.88 | $3.06 | $6.29 | $6.21 | $7.39 |
| QoQ Change | — | -20.3% | +54.1% | +11.7% | -50.0% | +53.3% | +32.9% | -30.4% | +30.9% | -103.1% | >999% | +2.5% | +32.3% | -67.4% | +356.1% | -37.3% | +105.6% | -1.3% | +19.0% |
| YoY Change | — | — | — | — | -31.4% | +32.0% | +13.8% | -29.0% | +85.7% | -103.7% | +13.1% | +66.4% | +68.2% | >999% | +101.7% | +23.4% | +91.8% | +480.4% | +51.4% |
EPS (Diluted) at Other Companies
Frequently Asked Questions
- What is Eli Lilly's eps (diluted)?
- Eli Lilly (LLY) reported eps (diluted) of $7.39 in Q4 2025.
- How has Eli Lilly's eps (diluted) changed year-over-year?
- Eli Lilly's eps (diluted) increased by 51.4% year-over-year, from $4.88 to $7.39.
- What is the long-term trend for Eli Lilly's eps (diluted)?
- Over 4 years (2021 to 2025), Eli Lilly's eps (diluted) has grown at a 39.2% compound annual growth rate (CAGR), from $6.12 to $22.95.
- What does eps (diluted) mean?
- The amount of profit per share if all possible stock options and convertible bonds were turned into actual shares.